South African Health Products Regulatory Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children over the age of 12
The South African Health Products Regulatory Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children over the age of 12.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthSouth African Health Products Regulatory Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children over the age of 12
View Premium plansBrowse free archive reportsThe South African Health Products Regulatory Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children over the age of 12.